Evaluation of Recombinant Factor VIIa in Patients With Severe Bleeding Due to Trauma
Evaluation of Recombinant Factor VIIa in Patients With Severe Bleeding Due to Trauma
This trial is conducted in the United States of America (USA). The purpose of this study is
 to evaluate the treatment of Recombinant Faction VIIa in Patients with Severe Bleeding Due to
 Trauma

 Please note that this trial and trial F7TRAUMA-1711 (NCT00184548) have been merged.
Inclusion Criteria:

 -  Trauma injury (blunt and/or penetrating) with evidence of active torso hemorrhage
 refectory to standard treatment